Hello all - we have some important news and encourage everyone to visit our website for additional information.
We announced that a recent independent review of our imaging data was positive and we are now setting a priority path to market for our MagSense imaging agent technology.
- Blinded review by expert panel of radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance Imaging (MRI).
- We are now prioritizing the development of our pipeline of tumour targeting MagSense® imaging agents for use with widely available commercial MRI systems as a faster path to patients and the market.
We will also be hosting a live webinar on 7 Feb @ 12pm AEDT to provide additional details and answer questions. We hope you join us!
Learn more: https://imagionbiosystems.com/news/priority-path-to-market-for-magsense-technology/
- Forums
- ASX - By Stock
- IBX
- Ann: Company Update - Phase 1 Study Independent Review
Ann: Company Update - Phase 1 Study Independent Review, page-2
-
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
-0.001(1.61%) |
Mkt cap ! $2.134M |
Open | High | Low | Value | Volume |
6.1¢ | 6.1¢ | 6.1¢ | $983 | 16.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16920 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 21383 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16920 | 0.060 |
1 | 15000 | 0.059 |
2 | 32250 | 0.058 |
1 | 40000 | 0.055 |
1 | 59181 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 21383 | 1 |
0.062 | 3988 | 3 |
0.065 | 9518 | 1 |
0.066 | 950 | 1 |
0.068 | 1245 | 1 |
Last trade - 10.47am 19/07/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |